Abrdn Life Sciences Investors (NYSE:HQL) Short Interest Update

Abrdn Life Sciences Investors (NYSE:HQL) saw a large decline in short interest in the month of November. As of November 30th, there was short interest totalling 33,800 shares, a decline of 54.4% from the November 15th total of 74,100 shares. Based on an average trading volume of 75,400 shares, the days-to-cover ratio is currently 0.4 days.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of HQL. Sanctuary Advisors LLC lifted its stake in shares of Abrdn Life Sciences Investors by 11.4% in the 3rd quarter. Sanctuary Advisors LLC now owns 13,256 shares of the company’s stock valued at $183,000 after purchasing an additional 1,355 shares during the last quarter. Needham Investment Management LLC raised its holdings in Abrdn Life Sciences Investors by 3.2% during the 3rd quarter. Needham Investment Management LLC now owns 352,719 shares of the company’s stock valued at $5,319,000 after buying an additional 10,904 shares during the period. Penserra Capital Management LLC purchased a new stake in Abrdn Life Sciences Investors during the 3rd quarter valued at $11,702,000. Kapstone Financial Advisors LLC purchased a new stake in Abrdn Life Sciences Investors during the 3rd quarter valued at $177,000. Finally, Ashton Thomas Securities LLC purchased a new stake in Abrdn Life Sciences Investors during the 3rd quarter valued at $148,000. 32.21% of the stock is owned by hedge funds and other institutional investors.

Abrdn Life Sciences Investors Stock Down 1.0 %

HQL traded down $0.14 on Friday, hitting $13.84. 73,123 shares of the company’s stock traded hands, compared to its average volume of 92,054. Abrdn Life Sciences Investors has a one year low of $12.76 and a one year high of $15.90. The company’s 50 day simple moving average is $14.58 and its 200-day simple moving average is $14.70.

Abrdn Life Sciences Investors Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 10th. Shareholders of record on Thursday, November 21st will be paid a $0.50 dividend. This is an increase from Abrdn Life Sciences Investors’s previous quarterly dividend of $0.49. The ex-dividend date of this dividend is Thursday, November 21st. This represents a $2.00 dividend on an annualized basis and a yield of 14.45%.

Abrdn Life Sciences Investors Company Profile

Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries.